ArrowMark Life Science Fund II, LP — Form D
ArrowMark Life Science Fund II, LP of Denver, CO, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-11-30. $71.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-11-30
- Form: D
- Accession: 0001209191-21-067087
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.7, 3C
- Amount sold: $71.9M
- Minimum investment: $1.0M
- Investors: 104
- Date of first sale: 2021-06-01
- Security types: fund interests
- SEC file number: 021-422861
Issuer
- Name: ArrowMark Life Science Fund II, LP
- CIK: 0001895193
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 100 Fillmore Street, Suite 325, Denver, CO, 80206
- Phone: 303-398-2929
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| N/A AMP Life Science GP II, LLC | Executive Officer | Denver, CO |
| N/A ArrowMark Colorado Holdings, LLC | Executive Officer | Denver, CO |
| N/A AMP Life Science GP II, LLC | Promoter | Denver, CO |
More